SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
20-Mar-23 6:51 PM View: | Lipocine Inc. (LPCN) | 20-Mar-23 | Private Purchase | 4,000 | $0.34 | $1,360.00 | 40% 10.13K to 14.13K | |
17-Dec-20 4:07 PM View: | Lipocine Inc. (LPCN) | 16-Dec-20 | Option Exercise | 5,250 | -- | -- | 108% 4.88K to 10.13K | |
02-Jan-18 6:15 PM View: | Lipocine Inc. (LPCN) | 29-Dec-17 | Option Exercise | 1,750 | -- | -- | 44% 4.0K to 5.75K | |
02-Jan-18 6:15 PM View: | Lipocine Inc. (LPCN) | 29-Dec-17 | Market Option Sale (Planned) | 875 | $3.47 | $3,033.36 | (15%) 5.75K to 4.88K | 51% |
10-Mar-17 4:15 PM View: | Commonwealth Biotechnologie... (INTI) | 08-Mar-17 | Payment of Exercise | 297,000 | $0.34 | $100,980.00 | (40%) 750.0K to 453.0K | (36%) |
10-Mar-17 4:15 PM View: | Commonwealth Biotechnologie... (INTI) | 08-Mar-17 | Option Exercise | 750,000 | -- | -- | 100% 0 to 750.0K | |
19-Nov-14 3:24 PM View: | Lipocine Inc. (LPCN) | 19-Nov-14 | Market Purchase | 4,000 | $5.14 | $20,560.00 | 100% 0 to 4.0K | (67%) |